Canopy Growth Corp (WEED : TSX)
Common Stock
$1.34
CAD
-0.03 (-2.19%)
Last updated: 2026-07-14
WEED
Canopy Growth Corp
WealthAwesomePerformance
1 Day
-2.19%
1 Week
-1.47%
1 Month
-4.96%
YTD
-18.29%
Key Statistics
Market Cap
$614.33M
52W High
$3.28
52W Low
$1.18
P/E Ratio
-
50 Day MA
$1.44
200 Day MA
$1.60
Beta
2.42
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/14/2026 | $1.36 | $1.36 | $1.34 | $1.34 | $1.34 | 681,648 |
| 7/13/2026 | $1.36 | $1.38 | $1.36 | $1.37 | $1.37 | 425,386 |
| 7/10/2026 | $1.39 | $1.40 | $1.36 | $1.37 | $1.37 | 504,033 |
| 7/9/2026 | $1.38 | $1.40 | $1.37 | $1.38 | $1.38 | 663,784 |
| 7/8/2026 | $1.36 | $1.38 | $1.35 | $1.37 | $1.37 | 578,415 |
| 7/7/2026 | $1.37 | $1.39 | $1.36 | $1.36 | $1.36 | 319,863 |
| 7/6/2026 | $1.45 | $1.45 | $1.37 | $1.37 | $1.37 | 1,492,169 |
| 7/3/2026 | $1.44 | $1.44 | $1.41 | $1.42 | $1.42 | 339,709 |
| 7/2/2026 | $1.36 | $1.49 | $1.36 | $1.43 | $1.43 | 2,183,836 |
| 6/30/2026 | $1.43 | $1.44 | $1.38 | $1.38 | $1.38 | 1,192,600 |
Analyst Price Targets
Based on analyst covering WEED
Wall Street analysts forecast WEED stock price to rise 50.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$2.02
+50.7% Upside
Current Price
C$1.34
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WEED's historical volatility
30-Day Vol
38.4%
Annualized
90-Day Vol
64.4%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$1.12
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.26 | C$1.11 – C$1.44 |
| 60 trading days | C$1.19 | C$0.99 – C$1.43 |
| 90 trading days | C$1.12 | C$0.89 – C$1.41 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Canopy Growth Corp
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies. In addition, the company operates e-commerce shop; medical cannabis online distribution platform; and an online medical cannabis clinic. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Abba Medix, Storz & Bickel, Wana, and Claybourne, Apollo, Canada House, R'belle, LowKey, MTL Cannabis, DeeLish, DOJA brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Financials
- Revenue (TTM)
- $284.60M
- EBITDA
- $-26.75M
- Profit Margin
- -92.38%
- ROE (TTM)
- -44.71%
- EPS (Diluted)
- -0.88
- Book Value
- 2.06
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
🔄 Recent Splits
1-for-10
Dec 20, 2023
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About WEED
Articles Featuring WEED.TO
Latest articles and analysis covering WEED.TO
Why Canopy Growth Corp stock is sliding today
Canopy Growth Corp's stock fell 2.82% today, closing at CA$1.38. While the company reported strong growth in its medical marijuana division, weaknesses in other areas raise concerns about its overall performance.
Why Canopy Growth Corp stock is skyrocketing today
Canopy Growth Corp is experiencing a significant stock price increase, primarily driven by impressive growth in its medical marijuana sales. However, investors should weigh this against the mixed performance in other business areas.
Why Canopy Growth Corp stock is rising today
Canopy Growth Corp's stock has risen by 3.41%, reflecting investor optimism following strategic acquisitions and revenue growth. The company is positioning itself as a leader in the medical cannabis market.
Why Canopy Growth Corp stock is gaining today
Canopy Growth Corp's stock has gained 0.74% today, reflecting investor optimism following its recent financial results that showed a 14% revenue increase in the last quarter. The company is positioning itself for future growth through strategic acquisitions and a focus on profitability.
Why Canopy Growth Corp stock is gaining today
Canopy Growth Corp is gaining momentum with a 1.50% increase in its stock price today, reflecting a recovery phase after years of turbulence. The company's recent financial results and strategic moves suggest a potential turnaround in its operations.
Why Canopy Growth Corp stock is sliding today
Canopy Growth Corp's stock slid 3.60% today, closing at CA$1.34. Despite announcing a 14% revenue increase in Q4 and strategic acquisitions, investor confidence remains shaky as the company continues to grapple with profitability and integration costs.
Why Canopy Growth Corp stock is sliding today
Canopy Growth Corp's stock fell by 3.60% in the latest trading session, highlighting the challenges the company faces in achieving profitability despite recent revenue growth.
Why Canopy Growth Corp stock is sliding today
Canopy Growth Corp's stock fell 2.80% today, closing at CA$1.39, as investors weigh the company's ongoing struggles against its recent financial improvements.
8 Best Marijuana Stocks In Canada for July 2026
According to Stats Canada, about one in five Canadians (aged 15 or older) reported using cannabis or derivative products in the last three months of 2020. It’s remarkable, considering cannabis was legalized in 2018 and marijuana derivates in 2019. It's a market with potential, so check out my list o
![8 Best Marijuana Stocks In Canada for [currentmonthyearfull]](https://lhajohzwizrsjmumhpjg.supabase.co/storage/v1/object/public/wealth-awesome/site-media/best-marijuana-stocks-in-canada_4-17-1024x538.jpg)
10 Best Day Trading Stocks in Canada for July 2026
Are you looking to day trade but don’t know which equities in Canada to consider as suitable stocks? Day trading is a tough undertaking. Across all day traders: - Almost 40% trade for only a month - 13% continue to trade for three years - 7% continue trading after five years Characteristics of great
![10 Best Day Trading Stocks in Canada for [currentmonthyearfull]](https://lhajohzwizrsjmumhpjg.supabase.co/storage/v1/object/public/wealth-awesome/site-media/best-day-trading-stocks-in-canada_3.jpg)